Latest News & Features
Americas
Israel-based pharmaceutical company Teva will have to fork out $1.2 billion after a long-running dispute with the US Federal Trade Commission over a controversial ‘pay-for-delay’ case was settled. 29 May 2015
Asia
If the proposals for the TPP trade agreement are accepted, a significant change in the patent law and practice of Vietnam would follow, as Tran Manh Hung and Bui Phuong of BMVN describe. 28 May 2015
Americas
Law firm Norton Rose Fulbright has hired Andres Liivak to its New York office. 28 May 2015
Americas
Acorda Therapeutics, the first company to be targeted through an inter partes review filed by US hedge fund manager Kyle Bass, has asked the US Patent and Trademark Office to reject the petition. 28 May 2015
Asia-Pacific
The Australian health minister has revealed a series of reforms that will aim to reduce spending on patented drugs from the pharmaceutical industry. 27 May 2015
Americas
A US appeals court has issued a mixed judgment in a patent dispute that saw Novartis file infringement claims against both Watson Pharmaceuticals and Par Pharmaceutical. 26 May 2015
Big Pharma
Teva has successfully defended two patents related to its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate) at the English High Court. 22 May 2015
Asia-Pacific
February’s amendments to the Australian IP Act seek to increase the effectiveness and efficiency of the country’s IP system. LSIPR takes a look at the major changes and considers who will benefit most in the life sciences sector. 21 May 2015
Americas
Gilead Sciences is facing a challenge to its attempt to obtain a patent for its hepatitis C drug Sovaldi in certain Asian, Latin American and European countries. 20 May 2015
Americas
Californian genetic analysis company Illumina has sued Ariosa Diagnostics for allegedly infringing a patent through its Harmony Prenatal Test. 19 May 2015